News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
News Conference News AHA 2018 PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure Michael O'Riordan November 11, 2018
News Conference News AHA 2018 DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors Todd Neale November 10, 2018
News Features Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program Michael O'Riordan October 29, 2018
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018
News Daily News Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’ Todd Neale September 13, 2018
News Industry News Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial August 27, 2018
News Daily News SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function Todd Neale July 02, 2018
News Conference News EuroPCR 2018 EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage Shelley Wood May 17, 2018
News Daily News Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval Michael O'Riordan May 01, 2018
News Daily News Time for Guidelines to Recommend ARBs Over ACE Inhibitors? Shelley Wood March 29, 2018
News Daily News Low BP Tied to Poor Outcomes in Hospitalized Patients With HFpEF Todd Neale February 20, 2018
News Daily News High-Sensitivity Troponin May Help Uncover Heart Failure Risk Todd Neale January 11, 2018
News Daily News Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis Caitlin E. Cox January 08, 2018